Showing results (211-220 of 425) with videos related to
Sort By:
Pageof 43
Biochemical Pharmacology|September 15, 1983
Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatromH Deckmyn, E Van Houtte, M Verstraete, et al.Experimental Hematology|March 1, 1977
Effect of furosemide on plasma fibrinolytic activity and urokinase excretionI S Chohan, I Singh, J Vermylen, et al.Trends in Pharmacological Sciences|April 1, 1991
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disordersP Gresele, H Deckmyn, G G Nenci, et al.Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1985
BM 13.177 selectively inhibits endoperoxide analogue induced vascular contractionsW J Janssens, H Deckmyn, P Gresele, et al.Drugs|June 1, 1986
Current issues in thrombosis prevention with antiplatelet drugsG de Gaetano, C Cerletti, E Dejana, et al.Eicosanoids|January 1, 1990
Urinary thromboxane B2 and 2,3-dinor-thromboxane B2 in the neonate born at full-term ageC Van Geet, J Arnout, E Eggermont, et al.Nuclear Medicine Communications|July 1, 1986
Evaluation of three methods of platelet labellingL Mortelmans, A Verbruggen, M De Roo, et al.Blood|May 16, 1998
Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc gamma RII receptor-mediated platelet activationM F Hoylaerts, C Thys, J Arnout, et al.Scandinavian Journal of Haematology|December 1, 1975
Activated reptilase clot retraction of dog platelet-rich plasma: differences with human platelet-rich plasmaF De Clerck, A Verheyen, J Vermylen, et al.Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Ambient air pollution and acute myocardial infarctionJ Vermylen, A Nemmar, B Nemery, et al.Pageof 43